Rekrutierende Studie = ; Fortlaufende Studie = ; Förderung durch ein IRDiRC-Mitglied =

Nationale klinische Studie(n)

FINNLAND

Finland
TURKU

A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalating Study Investigating the Efficacy and Safety of VR040 in the Treatment of Unpredictable 'Off' or End-of-Dose 'Wearing Off' Episodes in Patients With Advanced Idiopathic Parkinson's Disease (Phase II)

Biotie Therapies Corp

Mehr Details